Cargando…
Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial
BACKGROUND: In reality, pharmacotherapy still remains the most common treatment for insomnia. OBJECTIVE: This study aimed to examine the effectiveness of our internet-delivered computerized cognitive behavioral therapy (ICBT) program as an adjunct to usual care (UC) compared with UC alone in patient...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482403/ https://www.ncbi.nlm.nih.gov/pubmed/30973344 http://dx.doi.org/10.2196/12686 |
_version_ | 1783413880198791168 |
---|---|
author | Sato, Daisuke Yoshinaga, Naoki Nagai, Eiichi Nagai, Kazue Shimizu, Eiji |
author_facet | Sato, Daisuke Yoshinaga, Naoki Nagai, Eiichi Nagai, Kazue Shimizu, Eiji |
author_sort | Sato, Daisuke |
collection | PubMed |
description | BACKGROUND: In reality, pharmacotherapy still remains the most common treatment for insomnia. OBJECTIVE: This study aimed to examine the effectiveness of our internet-delivered computerized cognitive behavioral therapy (ICBT) program as an adjunct to usual care (UC) compared with UC alone in patients with insomnia who remain symptomatic following hypnotics. METHODS: We recruited 23 patients with insomnia who remained symptomatic following pharmacologic treatment including benzodiazepines, and we conducted an exploratory randomized controlled trial. The primary outcome was the Pittsburgh Sleep Quality Index (PSQI) at week 6 of the treatment. Secondary outcomes were sleep onset latency, total sleep time, sleep efficiency, number of awakenings, refreshment and soundness of sleep, anxiety by Hospital Anxiety and Depression Scale, depression measured by the Center for Epidemiologic Studies Depression Scale, and quality of life (QOL) measured by the EuroQol-5D. All parameters were measured at weeks 0 (baseline), 6 (postintervention), and 12 (follow-up). RESULTS: The adjusted mean reduction (−6.11) in PSQI at week 6 from baseline in the ICBT plus UC group was significantly (P<.001) larger than the adjusted mean reduction (0.40) in the UC alone group. Significant differences were also found in favor of ICBT plus UC for PSQI, sleep onset latency, sleep efficiency, number of awakenings, and depression at all assessment points. Refreshment, soundness of sleep, anxiety, and QOL improved by week 6 in ICBT plus UC compared with UC alone. There were no reports of adverse events in either group during the study. CONCLUSIONS: These results indicated that our 6-week ICBT program is an effective treatment adjunct to UC for improving insomnia and related symptoms even after unsuccessful pharmacotherapy. TRIAL REGISTRATION: University Hospital Medical Information Network Clinical Trials Registry: UMIN000021509; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023545 (Archived by WebCite at http://www.webcitation. org/75tCmwnYt). |
format | Online Article Text |
id | pubmed-6482403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-64824032019-05-08 Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial Sato, Daisuke Yoshinaga, Naoki Nagai, Eiichi Nagai, Kazue Shimizu, Eiji J Med Internet Res Original Paper BACKGROUND: In reality, pharmacotherapy still remains the most common treatment for insomnia. OBJECTIVE: This study aimed to examine the effectiveness of our internet-delivered computerized cognitive behavioral therapy (ICBT) program as an adjunct to usual care (UC) compared with UC alone in patients with insomnia who remain symptomatic following hypnotics. METHODS: We recruited 23 patients with insomnia who remained symptomatic following pharmacologic treatment including benzodiazepines, and we conducted an exploratory randomized controlled trial. The primary outcome was the Pittsburgh Sleep Quality Index (PSQI) at week 6 of the treatment. Secondary outcomes were sleep onset latency, total sleep time, sleep efficiency, number of awakenings, refreshment and soundness of sleep, anxiety by Hospital Anxiety and Depression Scale, depression measured by the Center for Epidemiologic Studies Depression Scale, and quality of life (QOL) measured by the EuroQol-5D. All parameters were measured at weeks 0 (baseline), 6 (postintervention), and 12 (follow-up). RESULTS: The adjusted mean reduction (−6.11) in PSQI at week 6 from baseline in the ICBT plus UC group was significantly (P<.001) larger than the adjusted mean reduction (0.40) in the UC alone group. Significant differences were also found in favor of ICBT plus UC for PSQI, sleep onset latency, sleep efficiency, number of awakenings, and depression at all assessment points. Refreshment, soundness of sleep, anxiety, and QOL improved by week 6 in ICBT plus UC compared with UC alone. There were no reports of adverse events in either group during the study. CONCLUSIONS: These results indicated that our 6-week ICBT program is an effective treatment adjunct to UC for improving insomnia and related symptoms even after unsuccessful pharmacotherapy. TRIAL REGISTRATION: University Hospital Medical Information Network Clinical Trials Registry: UMIN000021509; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023545 (Archived by WebCite at http://www.webcitation. org/75tCmwnYt). JMIR Publications 2019-04-11 /pmc/articles/PMC6482403/ /pubmed/30973344 http://dx.doi.org/10.2196/12686 Text en ©Daisuke Sato, Naoki Yoshinaga, Eiichi Nagai, Kazue Nagai, Eiji Shimizu. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 11.04.2019. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Sato, Daisuke Yoshinaga, Naoki Nagai, Eiichi Nagai, Kazue Shimizu, Eiji Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial |
title | Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial |
title_full | Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial |
title_fullStr | Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial |
title_full_unstemmed | Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial |
title_short | Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial |
title_sort | effectiveness of internet-delivered computerized cognitive behavioral therapy for patients with insomnia who remain symptomatic following pharmacotherapy: randomized controlled exploratory trial |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482403/ https://www.ncbi.nlm.nih.gov/pubmed/30973344 http://dx.doi.org/10.2196/12686 |
work_keys_str_mv | AT satodaisuke effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial AT yoshinaganaoki effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial AT nagaieiichi effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial AT nagaikazue effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial AT shimizueiji effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial |